SANOFI (SAN.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:SAN • FR0000120578

80.36 EUR
-0.73 (-0.9%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

SAN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Pharmaceuticals industry. While SAN is still in line with the averages on profitability rating, there are concerns on its financial health. SAN has a correct valuation and a medium growth rate. SAN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year SAN was profitable.
  • Each year in the past 5 years SAN has been profitable.
  • SAN had a positive operating cash flow in each of the past 5 years.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of SAN (10.63%) is better than 76.36% of its industry peers.
  • The Return On Equity of SAN (18.84%) is better than 61.82% of its industry peers.
  • With a decent Return On Invested Capital value of 13.35%, SAN is doing good in the industry, outperforming 65.45% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SAN is significantly below the industry average of 14.23%.
  • The 3 year average ROIC (7.41%) for SAN is below the current ROIC(13.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 20.63%, SAN is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • SAN's Profit Margin has declined in the last couple of years.
  • SAN has a Operating Margin of 23.61%. This is comparable to the rest of the industry: SAN outperforms 56.36% of its industry peers.
  • In the last couple of years the Operating Margin of SAN has grown nicely.
  • The Gross Margin of SAN (72.29%) is comparable to the rest of the industry.
  • SAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SAN is still creating some value.
  • SAN has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SAN has been reduced compared to 5 years ago.
  • SAN has a worse debt/assets ratio than last year.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • A Debt/Equity ratio of 0.18 indicates that SAN is not too dependend on debt financing.
  • The Debt to Equity ratio of SAN (0.18) is better than 78.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.71
WACC7.8%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SAN has a Current Ratio of 1.06. This is a normal value and indicates that SAN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.06, SAN is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.30 indicates that SAN may have some problems paying its short term obligations.
  • SAN has a Quick ratio of 0.30. This is amonst the worse of the industry: SAN underperforms 89.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for SAN have decreased by -8.39% in the last year.
  • Measured over the past 5 years, SAN shows a small growth in Earnings Per Share. The EPS has been growing by 3.37% on average per year.
  • Looking at the last year, SAN shows a small growth in Revenue. The Revenue has grown by 5.49% in the last year.
  • The Revenue has been growing slightly by 4.57% on average over the past years.
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.19% on average over the next years. This is quite good.
  • SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.52% yearly.
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • SAN is valuated reasonably with a Price/Earnings ratio of 11.41.
  • Based on the Price/Earnings ratio, SAN is valued cheaply inside the industry as 87.27% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of SAN to the average of the S&P500 Index (27.92), we can say SAN is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.51, the valuation of SAN can be described as reasonable.
  • SAN's Price/Forward Earnings ratio is rather cheap when compared to the industry. SAN is cheaper than 89.09% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.78. SAN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.41
Fwd PE 9.51
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • SAN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of SAN may justify a higher PE ratio.
  • A more expensive valuation may be justified as SAN's earnings are expected to grow with 12.69% in the coming years.
PEG (NY)0.57
PEG (5Y)3.38
EPS Next 2Y12.73%
EPS Next 3Y12.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 5.35%, SAN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.95, SAN pays a better dividend. On top of this SAN pays more dividend than 94.55% of the companies listed in the same industry.
  • SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 5.35%

5.2 History

  • The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 34.36% of the earnings are spent on dividend by SAN. This is a low number and sustainable payout ratio.
  • The dividend of SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.36%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
SAN.PA Dividend Payout.SAN.PA Dividend Payout, showing the Payout Ratio.SAN.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI

EPA:SAN (2/6/2026, 7:00:00 PM)

80.36

-0.73 (-0.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap194.09B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts79.31
Price Target101.26 (26.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.35%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-4.87%
PT rev (3m)-4.86%
EPS NQ rev (1m)2.75%
EPS NQ rev (3m)-0.03%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)-2.58%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 11.41
Fwd PE 9.51
P/S 2.9
P/FCF N/A
P/OCF N/A
P/B 2.65
P/tB 44.15
EV/EBITDA N/A
EPS(TTM)7.04
EY8.76%
EPS(NY)8.45
Fwd EY10.52%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)0.57
PEG (5Y)3.38
Graham Number69.32
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.8%
ROIC/WACC1.71
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y10.94%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SAN.PA FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.


Can you provide the valuation status for SANOFI?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (SAN.PA) has a profitability rating of 6 / 10.


What is the valuation of SANOFI based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 11.41 and the Price/Book (PB) ratio is 2.65.


How financially healthy is SANOFI?

The financial health rating of SANOFI (SAN.PA) is 3 / 10.